Quick Answer
Exousia Bio, Inc. reported Total Assets of $0.00 for fiscal year 2025.
Exousia Bio, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $0.00 | -100.0% |
| 2024 | $27.5K | -25.9% |
| 2023 | $37.0K | -31.4% |
| 2022 | $54.0K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | $22.05M | +88620.8% | — |
| August 31, 2025 | $0.00 | -100.0% | — |
| May 31, 2025 | $0.00 | -100.0% | — |
| February 28, 2025 | $0.00 | -100.0% | -100.0% |
| November 30, 2024 | $24.9K | -7.1% | -11.1% |
| August 31, 2024 | $28.0K | +4.2% | +1.8% |
| May 31, 2024 | $27.5K | -25.9% | +1.9% |
| February 29, 2024 | $26.9K | -27.2% | +0.7% |
- Exousia Bio, Inc. showed a decrease of -100.0% in Total Assets compared to the prior fiscal year.
- Over the 2022–2025 period, Exousia Bio, Inc.’s total assets has declined by 100.0% (from $54.0 thousand to $0.00).
- The most recent figure is from Exousia Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on October 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: